The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis

Abstract The SEPT9 gene methylation assay is the first FDA-approved blood assay for colorectal cancer (CRC) screening. Fecal immunochemical test (FIT), FIT-DNA test and CEA assay are also in vitro diagnostic (IVD) tests used in CRC screening. This meta-analysis aims to review the SEPT9 assay perform...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lele Song, Jia Jia, Xiumei Peng, Wenhua Xiao, Yuemin Li
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/85bc8435fe9c4196991cda2e5dc58d96
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!